As of 2026-03-29, the Relative Valuation of Inhibrx Inc (INBX) is (131.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.39 USD, the upside of Inhibrx Inc based on Relative Valuation is -325.6%.
The range of the Relative Valuation is (121.23) - (140.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.2x - 22.5x | 19.6x |
| Forward P/E multiples | 17.4x - 21.1x | 20.0x |
| Fair Price | (121.23) - (140.66) | (131.74) |
| Upside | -307.6% - -340.9% | -325.6% |
| Date | P/E |
| 2026-03-24 | -9.49 |
| 2026-03-23 | -9.71 |
| 2026-03-20 | -9.16 |
| 2026-03-19 | -9.75 |
| 2026-03-18 | -10.32 |
| 2026-03-17 | -10.48 |
| 2026-03-16 | -10.41 |
| 2026-03-13 | -10.33 |
| 2026-03-12 | -10.42 |
| 2026-03-11 | -11.05 |
| 2026-03-10 | -10.77 |
| 2026-03-09 | -10.80 |
| 2026-03-06 | -10.40 |
| 2026-03-05 | -10.62 |
| 2026-03-04 | -11.22 |
| 2026-03-03 | -11.17 |
| 2026-03-02 | -11.65 |
| 2026-02-27 | -11.14 |
| 2026-02-26 | -11.61 |
| 2026-02-25 | -12.06 |
| 2026-02-24 | -11.95 |
| 2026-02-23 | -11.51 |
| 2026-02-20 | -11.82 |
| 2026-02-19 | -12.19 |
| 2026-02-18 | -12.26 |
| 2026-02-17 | -11.84 |
| 2026-02-13 | -11.39 |
| 2026-02-12 | -12.34 |
| 2026-02-11 | -12.32 |
| 2026-02-10 | -12.52 |
| 2026-02-09 | -13.00 |
| 2026-02-06 | -12.61 |
| 2026-02-05 | -12.25 |
| 2026-02-04 | -12.41 |
| 2026-02-03 | -12.79 |
| 2026-02-02 | -12.36 |
| 2026-01-30 | -11.46 |
| 2026-01-29 | -10.91 |
| 2026-01-28 | -11.12 |
| 2026-01-27 | -11.05 |
| 2026-01-26 | -10.82 |
| 2026-01-23 | -11.22 |
| 2026-01-22 | -11.95 |
| 2026-01-21 | -11.29 |
| 2026-01-20 | -10.96 |
| 2026-01-16 | -10.86 |
| 2026-01-15 | -10.79 |
| 2026-01-14 | -11.41 |
| 2026-01-13 | -11.01 |
| 2026-01-12 | -11.41 |